 |
74 Diseases |  |
2 Trials |
|
2 Trials |  |
73 News |  |
| 12» |
- |||| Genotropin (somatropin) / Pfizer
New P3 trial: Study of the efficacy and safety of somatropin in Japanese participants with PWS (EUDRACT) - Sep 19, 2024
P3, N=33, , Sponsor: Pfizer, Inc.
- ||||| Genotropin (somatropin) / Pfizer
Trial completion, Enrollment change: Growth Hormone Therapy for Muscle Regeneration in Severely Burned Patients (clinicaltrials.gov) - Feb 13, 2023
P2/3, N=13, Completed, Sponsor: The University of Texas Medical Branch, Galveston
Active, not recruiting --> Completed | N=64 --> 13
- |||| Genotropin (somatropin) / Pfizer
Enrollment closed: Growth Hormone Therapy for Muscle Regeneration in Severely Burned Patients (clinicaltrials.gov) - Feb 21, 2022
P2/3, N=64, Active, not recruiting, Sponsor: The University of Texas Medical Branch, Galveston
Active, not recruiting --> Completed | N=64 --> 13 Recruiting --> Active, not recruiting
- || Genotropin (somatropin) / Pfizer
Enrollment closed: Study of the Efficacy and Safety of Somatropin in Japanese Participants With PWS (clinicaltrials.gov) - Jan 27, 2022
P3, N=32, Active, not recruiting, Sponsor: Pfizer
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- |||| Genotropin (somatropin) / Pfizer
Enrollment open, Trial completion date, Trial primary completion date: Growth Hormone Therapy for Muscle Regeneration in Severely Burned Patients (clinicaltrials.gov) - Jun 11, 2021
P2/3, N=64, Recruiting, Sponsor: The University of Texas Medical Branch, Galveston
Recruiting --> Active, not recruiting Active, not recruiting --> Recruiting | Trial completion date: Dec 2021 --> Dec 2023 | Trial primary completion date: Aug 2021 --> Aug 2023
- || Genotropin (somatropin) / Pfizer
Enrollment open: Study of the Efficacy and Safety of Somatropin in Japanese Participants With PWS (clinicaltrials.gov) - Feb 22, 2021
P3, N=30, Recruiting, Sponsor: Pfizer
Active, not recruiting --> Recruiting | Trial completion date: Dec 2021 --> Dec 2023 | Trial primary completion date: Aug 2021 --> Aug 2023 Not yet recruiting --> Recruiting
- |||| Genotropin (somatropin) / Pfizer
New P3 trial: Study of the Efficacy and Safety of Somatropin in Japanese Participants With PWS (clinicaltrials.gov) - Jan 5, 2021
P3, N=30, Not yet recruiting, Sponsor: Pfizer
- ||| Genotropin (somatropin) / Pfizer
Trial completion date, Trial primary completion date: Growth Hormone Therapy for Muscle Regeneration in Severely Burned Patients (clinicaltrials.gov) - Dec 22, 2020
P2/3, N=64, Active, not recruiting, Sponsor: The University of Texas Medical Branch, Galveston
Not yet recruiting --> Recruiting Trial completion date: Oct 2020 --> Dec 2021 | Trial primary completion date: Oct 2020 --> Aug 2021
- ||||| Lagova (somatrogon) / OPKO Health, Pfizer, Genotropin (somatropin) / Pfizer
Trial completion: Patient Perception of Treatment Burden in Weekly Versus Daily Growth Hormone Injections in Children With GHD (clinicaltrials.gov) - Sep 16, 2020
P3, N=87, Completed, Sponsor: Pfizer
Trial completion date: Oct 2020 --> Dec 2021 | Trial primary completion date: Oct 2020 --> Aug 2021 Recruiting --> Completed
- |||| Genotropin (somatropin) / Pfizer
New P3 trial: GGAP: Global Growth Hormone Study in Adults With Prader-Willi Syndrome (clinicaltrials.gov) - Jul 23, 2020
P3, N=50, Not yet recruiting, Sponsor: Erasmus Medical Center
- ||| Lagova (somatrogon) / OPKO Health, Pfizer, Genotropin (somatropin) / Pfizer
Trial completion date, Trial primary completion date: Patient Perception of Treatment Burden in Weekly Versus Daily Growth Hormone Injections in Children With GHD (clinicaltrials.gov) - Dec 17, 2019
P3, N=90, Recruiting, Sponsor: Pfizer
Recruiting --> Completed Trial completion date: Mar 2020 --> Sep 2020 | Trial primary completion date: Mar 2020 --> Sep 2020
- ||| Genotropin (somatropin) / Pfizer
Trial completion: Study of Growth Hormone and Bone in Obesity (clinicaltrials.gov) - Jul 8, 2019
P=N/A, N=75, Completed, Sponsor: Massachusetts General Hospital
Trial completion date: Mar 2020 --> Sep 2020 | Trial primary completion date: Mar 2020 --> Sep 2020 Active, not recruiting --> Completed
- |||| Lagova (somatrogon) / OPKO Health, Pfizer, Genotropin (somatropin) / Pfizer
Enrollment open: Patient Perception of Treatment Burden in Weekly Versus Daily Growth Hormone Injections in Children With GHD (clinicaltrials.gov) - Mar 14, 2019
P3, N=90, Recruiting, Sponsor: Pfizer
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- |||||||| Lagova (somatrogon) / OPKO Health, Pfizer, Genotropin (somatropin) / Pfizer
New P3 trial: Patient Perception of Treatment Burden in Weekly Versus Daily Growth Hormone Injections in Children With GHD (clinicaltrials.gov) - Feb 6, 2019
P3, N=90, Not yet recruiting, Sponsor: Pfizer
- |||| Genotropin (somatropin) / Pfizer
Enrollment closed: Growth Hormone Therapy for Muscle Regeneration in Severely Burned Patients (clinicaltrials.gov) - Jan 18, 2019
P2/3, N=62, Active, not recruiting, Sponsor: The University of Texas Medical Branch, Galveston
Not yet recruiting --> Recruiting Suspended --> Active, not recruiting
- ||||||| Genotropin (somatropin) / Pfizer
Trial completion date, Trial suspension, Trial primary completion date: Growth Hormone Therapy for Muscle Regeneration in Severely Burned Patients (clinicaltrials.gov) - Jan 17, 2019
P2/3, N=62, Suspended, Sponsor: The University of Texas Medical Branch, Galveston
Suspended --> Active, not recruiting Trial completion date: Oct 2019 --> Oct 2020 | Recruiting --> Suspended | Trial primary completion date: Oct 2019 --> Oct 2020
- ||| Genotropin (somatropin) / Pfizer
Trial completion: A Prospective Non-Interventional Study Protocol With Primary Data Collection - Assessment Of The Long Term Treatment Outcomes Of Genotropin Treatment In Growth Hormone Deficiency (GHD) Patients (clinicaltrials.gov) - Dec 5, 2018
P=N/A, N=378, Completed, Sponsor: Pfizer
Trial completion date: Oct 2019 --> Oct 2020 | Recruiting --> Suspended | Trial primary completion date: Oct 2019 --> Oct 2020 Active, not recruiting --> Completed
- |||| Genotropin (somatropin) / Pfizer
Trial completion, Enrollment change: Short Stature Related Distress (clinicaltrials.gov) - Dec 20, 2017
P4, N=60, Completed, Sponsor: Rabin Medical Center
Active, not recruiting --> Completed Active, not recruiting --> Completed | N=90 --> 60
- ||| Genotropin (somatropin) / Pfizer
Enrollment closed, Enrollment change: Short Stature Related Distress (clinicaltrials.gov) - Oct 4, 2017
P4, N=90, Active, not recruiting, Sponsor: Rabin Medical Center
Active, not recruiting --> Completed | N=90 --> 60 Recruiting --> Active, not recruiting | N=120 --> 90
- || Genotropin (somatropin) / Pfizer
Enrollment change: A Prospective Non-Interventional Study Protocol With Primary Data Collection - Assessment Of The Long Term Treatment Outcomes Of Genotropin Treatment In Growth Hormone Deficiency (GHD) Patients (clinicaltrials.gov) - Aug 4, 2017
P=N/A, N=372, Active, not recruiting, Sponsor: Pfizer
Recruiting --> Active, not recruiting | N=120 --> 90 N=900 --> 372
- || Genotropin (somatropin) / Pfizer
Enrollment closed, Trial primary completion date: Study of Growth Hormone and Bone in Obesity (clinicaltrials.gov) - May 9, 2017
P=N/A, N=75, Active, not recruiting, Sponsor: Massachusetts General Hospital
N=900 --> 372 Recruiting --> Active, not recruiting | Trial primary completion date: Nov 2017 --> Nov 2018
- || Genotropin (somatropin) / Pfizer
Enrollment closed: A Prospective Non-Interventional Study Protocol With Primary Data Collection - Assessment Of The Long Term Treatment Outcomes Of Genotropin Treatment In Growth Hormone Deficiency (GHD) Patients (clinicaltrials.gov) - Apr 25, 2017
P=N/A, N=900, Active, not recruiting, Sponsor: Pfizer
Recruiting --> Active, not recruiting | Trial primary completion date: Nov 2017 --> Nov 2018 Recruiting --> Active, not recruiting
- ||| Genotropin (somatropin) / Pfizer
Trial completion: Special Investigation Of Genotropin Long Follow-Up For Patients With A Small For Gestational Age "Scoped for Japanese" (clinicaltrials.gov) - Apr 19, 2017
P=N/A, N=488, Completed, Sponsor: Pfizer
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- ||||||| rhGH-Emisphere (somatropin oral, oral recombinant human growth hormone) / Novo Nordisk, Ligand, Genotropin (somatropin) / Pfizer, Nutropin AQ (somatropin) / Ipsen, Roche
Trial completion, Combination therapy: ThrasherAI: Aromatase Inhibitors, Alone And In Combination With Growth Hormone In Adolescent Boys With Idiopathic Short Stature (clinicaltrials.gov) - Sep 23, 2016
P3, N=77, Completed, Sponsor: Nemours Children's Clinic
Active, not recruiting --> Completed Active, not recruiting --> Completed
- |||||||||| Genotropin (somatropin) / Pfizer
New P2/3 trial: Individualizing Dose of Growth Hormone to Maintain Normal Growth Velocity After Fulfilled Catch up Growth in Children (clinicaltrials.gov) - Aug 26, 2016
P2/3, N=99, Completed, Sponsor: Göteborg University
- || Genotropin (somatropin) / Pfizer
Trial primary completion date: Special Investigation Of Genotropin Long Follow-Up For Patients With A Small For Gestational Age "Scoped for Japanese" (clinicaltrials.gov) - Mar 5, 2016
P=N/A, N=500, Active, not recruiting, Sponsor: Pfizer
Active, not recruiting --> Completed Trial primary completion date: Aug 2016 --> Nov 2016
- |||| Genotropin (somatropin) / Pfizer
Trial completion: Long Term Study of Genotropin (Somatropin) for Short Children Born Small for Gestational Age (SGA) (clinicaltrials.gov) - Oct 21, 2015
P4, N=62, Completed, Sponsor: Pfizer
Trial primary completion date: Aug 2016 --> Nov 2016 Active, not recruiting --> Completed
- | Genotropin (somatropin) / Pfizer
Phase classification: A Prospective Non-Interventional Study Protocol With Primary Data Collection - Assessment Of The Long Term Treatment Outcomes Of Genotropin Treatment In Growth Hormone Deficiency (GHD) Patients (clinicaltrials.gov) - Sep 2, 2015
P4, N=900, Recruiting, Sponsor: Pfizer
Active, not recruiting --> Completed Phase classification: P=N/A --> P4
- || Genotropin (somatropin) / Pfizer
Phase classification, Trial primary completion date: Special Investigation Of Genotropin Long Follow-Up For Patients With A Small For Gestational Age "Scoped for Japanese" (clinicaltrials.gov) - Aug 22, 2015
P=N/A, N=500, Active, not recruiting, Sponsor: Pfizer
Phase classification: P=N/A --> P4 Trial primary completion date: May 2016 --> Aug 2016 | Phase classification: P4 --> PN/A
- | Genotropin (somatropin) / Pfizer
Phase classification: A Prospective Non-Interventional Study Protocol With Primary Data Collection - Assessment Of The Long Term Treatment Outcomes Of Genotropin Treatment In Growth Hormone Deficiency (GHD) Patients (clinicaltrials.gov) - Jul 15, 2015
P=N/A, N=900, Recruiting, Sponsor: Pfizer
Trial primary completion date: May 2016 --> Aug 2016 | Phase classification: P4 --> PN/A Phase classification: P4 --> P=N/A
- ||| Genotropin (somatropin) / Pfizer
Enrollment closed, Trial primary completion date: Special Investigation Of Genotropin Long Follow-Up For Patients With A Small For Gestational Age "Scoped for Japanese" (clinicaltrials.gov) - Jun 12, 2015
P4, N=500, Active, not recruiting, Sponsor: Pfizer
Phase classification: P4 --> P=N/A Enrolling by invitation --> Active, not recruiting | Trial primary completion date: Jul 2018 --> May 2016
- Genotropin (somatropin) / Pfizer
Enrollment change: Treatment Of Adult Growth Hormone Deficiency After Traumatic Brain Injury. (clinicaltrials.gov) - Apr 22, 2015
P4, N=0, Withdrawn, Sponsor: Pfizer
Enrolling by invitation --> Active, not recruiting | Trial primary completion date: Jul 2018 --> May 2016 N=120 --> 0
- Genotropin (somatropin) / Pfizer
Enrollment change: Safety Study In Patients Who Were Born Small And Short And Were Treated With Growth Hormone To Achieve Normal Height (clinicaltrials.gov) - Apr 22, 2015
P4, N=0, Withdrawn, Sponsor: Pfizer
N=120 --> 0 N=90 --> 0
- | Genotropin (somatropin) / Pfizer
Phase classification: Special Investigation Of Genotropin Long Follow-Up For Patients With A Small For Gestational Age "Scoped for Japanese" (clinicaltrials.gov) - Apr 22, 2015
P4, N=500, Enrolling by invitation, Sponsor: Pfizer
N=90 --> 0 Phase classification: P=N/A --> P4
- || Genotropin (somatropin) / Pfizer
Enrollment status: A Prospective Non-Interventional Study Protocol With Primary Data Collection - Assessment Of The Long Term Treatment Outcomes Of Genotropin Treatment In Growth Hormone Deficiency (GHD) Patients (clinicaltrials.gov) - Feb 9, 2015
P4, N=900, Recruiting, Sponsor: Pfizer
Phase classification: P=N/A --> P4 Enrolling by invitation --> Recruiting
- ||||||| Genotropin (somatropin) / Pfizer
Trial completion: Evolution Of Growth Rate In Children With Growth Retardation Due to Glucocorticosteroid Therapy And Treated By Genotonorm (clinicaltrials.gov) - Jan 13, 2015
P3, N=100, Completed, Sponsor: Pfizer
Enrolling by invitation --> Recruiting Active, not recruiting --> Completed
- ||||| Genotropin (somatropin) / Pfizer
Enrollment closed: Evolution Of Growth Rate In Children With Growth Retardation Due to Glucocorticosteroid Therapy And Treated By Genotonorm (clinicaltrials.gov) - Dec 24, 2014
P3, N=100, Active, not recruiting, Sponsor: Pfizer
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- || Genotropin (somatropin) / Pfizer
Trial primary completion date: A Prospective Non-Interventional Study Protocol With Primary Data Collection - Assessment Of The Long Term Treatment Outcomes Of Genotropin Treatment In Growth Hormone Deficiency (GHD) Patients (clinicaltrials.gov) - Dec 19, 2014
P4, N=900, Enrolling by invitation, Sponsor: Pfizer
Recruiting --> Active, not recruiting Trial primary completion date: Dec 2017 --> Dec 2018
- || Genotropin (somatropin) / Pfizer
Enrollment status, Phase classification: A Prospective Non-Interventional Study Protocol With Primary Data Collection - Assessment Of The Long Term Treatment Outcomes Of Genotropin Treatment In Growth Hormone Deficiency (GHD) Patients (clinicaltrials.gov) - Nov 28, 2014
P4, N=900, Enrolling by invitation, Sponsor: Pfizer
Trial primary completion date: Dec 2017 --> Dec 2018 Recruiting --> Enrolling by invitation | Phase classification: PN/A --> P4
- || Genotropin (somatropin) / Pfizer
Trial primary completion date: Short Stature Related Distress (clinicaltrials.gov) - Nov 7, 2014
P4, N=120, Recruiting, Sponsor: Rabin Medical Center
Recruiting --> Enrolling by invitation | Phase classification: PN/A --> P4 Trial primary completion date: Sep 2015 --> Sep 2017
- || Genotropin (somatropin) / Pfizer
Trial primary completion date: Long Term Study of Genotropin (Somatropin) for Short Children Born Small for Gestational Age (SGA) (clinicaltrials.gov) - Nov 4, 2014
P4, N=62, Active, not recruiting, Sponsor: Pfizer
Trial primary completion date: Sep 2015 --> Sep 2017 Trial primary completion date: Sep 2014 --> Sep 2015
- Genotropin (somatropin) / Pfizer
Phase classification: EGN: Genotropin Treatment In Very Young Children Born Small For Gestational Age (clinicaltrials.gov) - Nov 4, 2014
P3, N=43, Completed, Sponsor: Pfizer
Trial primary completion date: Sep 2014 --> Sep 2015 Phase classification: P2/3 --> P3
- || Genotropin (somatropin) / Pfizer
Trial primary completion date: Long Term Study of Genotropin (Somatropin) for Short Children Born Small for Gestational Age (SGA) (clinicaltrials.gov) - Sep 9, 2014
P4, N=62, Active, not recruiting, Sponsor: Pfizer
Phase classification: P2/3 --> P3 Trial primary completion date: Sep 2015 --> Sep 2014
- | Genotropin (somatropin) / Pfizer
Phase classification: Special Investigation Of Genotropin Long Follow-Up For Patients With A Small For Gestational Age "Scoped for Japanese" (clinicaltrials.gov) - Sep 5, 2014
P=N/A, N=500, Enrolling by invitation, Sponsor: Pfizer
Trial primary completion date: Sep 2015 --> Sep 2014 Phase classification: P4 --> P=N/A
- |||||| Genotropin (somatropin) / Pfizer
Enrollment open: Evolution Of Growth Rate In Children With Growth Retardation Due to Glucocorticosteroid Therapy And Treated By Genotonorm (clinicaltrials.gov) - Aug 15, 2014
P3, N=120, Recruiting, Sponsor: Pfizer
Phase classification: P4 --> P=N/A Active, not recruiting --> Recruiting
- || Genotropin (somatropin) / Pfizer
Trial primary completion date: Long Term Study of Genotropin (Somatropin) for Short Children Born Small for Gestational Age (SGA) (clinicaltrials.gov) - Jun 26, 2014
P4, N=62, Active, not recruiting, Sponsor: Pfizer
Active, not recruiting --> Recruiting Trial primary completion date: Apr 2014 --> May 2014
- || Genotropin (somatropin) / Pfizer
Trial completion date: Long Term Study of Genotropin (Somatropin) for Short Children Born Small for Gestational Age (SGA) (clinicaltrials.gov) - May 13, 2014
P4, N=62, Active, not recruiting, Sponsor: Pfizer
Trial primary completion date: Apr 2014 --> May 2014 Trial completion date: Apr 2014 --> May 2014
- Genotropin (somatropin) / Pfizer
Trial termination: Recombinant Human Growth Hormone (RH-GH) For Accelerating Immune Reconstitution Post Unrelated Cord Blood Transplant (clinicaltrials.gov) - Mar 17, 2014
P1, N=14, Terminated, Sponsor: Mitchell Horwitz, MD
Trial completion date: Apr 2014 --> May 2014 Active, not recruiting --> Terminated; Study was terminated early due to low accrual.
- | Genotropin (somatropin) / Pfizer
Trial completion: The Effect of Low-Dose Human Growth Hormone Therapy in HIV Infected Patients (clinicaltrials.gov) - Feb 22, 2014
P4, N=46, Completed, Sponsor: Hvidovre University Hospital
Active, not recruiting --> Terminated; Study was terminated early due to low accrual. No longer recruiting --> Completed
- || Genotropin (somatropin) / Pfizer
Trial completion: EGN: Genotropin Treatment In Very Young Children Born Small For Gestational Age (clinicaltrials.gov) - Jan 20, 2014
P2/3, N=43, Completed, Sponsor: Pfizer
No longer recruiting --> Completed Active, not recruiting --> Completed